RHHBY
Price
$39.63
Change
-$0.65 (-1.61%)
Updated
Jul 15 closing price
Capitalization
250.69B
8 days until earnings call
SNPHF
Price
$11.45
Change
+$0.45 (+4.09%)
Updated
Jun 11 closing price
Capitalization
3.26B
Interact to see
Advertisement

RHHBY vs SNPHF

Header iconRHHBY vs SNPHF Comparison
Open Charts RHHBY vs SNPHFBanner chart's image
Roche Holding
Price$39.63
Change-$0.65 (-1.61%)
Volume$891.57K
Capitalization250.69B
Santen Pharmaceutical
Price$11.45
Change+$0.45 (+4.09%)
Volume$1K
Capitalization3.26B
RHHBY vs SNPHF Comparison Chart in %
Loading...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHBY vs. SNPHF commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHBY is a Hold and SNPHF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (RHHBY: $40.20 vs. SNPHF: $11.45)
Brand notoriety: RHHBY and SNPHF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHBY: 99% vs. SNPHF: 146%
Market capitalization -- RHHBY: $250.69B vs. SNPHF: $3.26B
RHHBY [@Pharmaceuticals: Major] is valued at $250.69B. SNPHF’s [@Pharmaceuticals: Major] market capitalization is $3.26B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHBY’s FA Score shows that 2 FA rating(s) are green whileSNPHF’s FA Score has 0 green FA rating(s).

  • RHHBY’s FA Score: 2 green, 3 red.
  • SNPHF’s FA Score: 0 green, 5 red.
According to our system of comparison, RHHBY is a better buy in the long-term than SNPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHBY’s TA Score shows that 5 TA indicator(s) are bullish while SNPHF’s TA Score has 3 bullish TA indicator(s).

  • RHHBY’s TA Score: 5 bullish, 4 bearish.
  • SNPHF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, both RHHBY and SNPHF are a good buy in the short-term.

Price Growth

RHHBY (@Pharmaceuticals: Major) experienced а -1.64% price change this week, while SNPHF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.47%. For the same industry, the average monthly price growth was +1.27%, and the average quarterly price growth was +11.07%.

Reported Earning Dates

RHHBY is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.47% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($251B) has a higher market cap than SNPHF($3.26B). RHHBY has higher P/E ratio than SNPHF: RHHBY (19.46) vs SNPHF (15.31). RHHBY YTD gains are higher at: 17.396 vs. SNPHF (8.716). RHHBY has higher annual earnings (EBITDA): 19.1B vs. SNPHF (17.2B). SNPHF has more cash in the bank: 62.3B vs. RHHBY (7.51B). RHHBY has less debt than SNPHF: RHHBY (25.4B) vs SNPHF (40.1B). SNPHF has higher revenues than RHHBY: SNPHF (270B) vs RHHBY (60B).
RHHBYSNPHFRHHBY / SNPHF
Capitalization251B3.26B7,690%
EBITDA19.1B17.2B111%
Gain YTD17.3968.716200%
P/E Ratio19.4615.31127%
Revenue60B270B22%
Total Cash7.51B62.3B12%
Total Debt25.4B40.1B63%
FUNDAMENTALS RATINGS
RHHBY vs SNPHF: Fundamental Ratings
RHHBY
SNPHF
OUTLOOK RATING
1..100
5449
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
90100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5353
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (50) in the null industry is in the same range as SNPHF (50). This means that RHHBY’s stock grew similarly to SNPHF’s over the last 12 months.

RHHBY's Profit vs Risk Rating (90) in the null industry is in the same range as SNPHF (100). This means that RHHBY’s stock grew similarly to SNPHF’s over the last 12 months.

RHHBY's SMR Rating (100) in the null industry is in the same range as SNPHF (100). This means that RHHBY’s stock grew similarly to SNPHF’s over the last 12 months.

RHHBY's Price Growth Rating (53) in the null industry is in the same range as SNPHF (53). This means that RHHBY’s stock grew similarly to SNPHF’s over the last 12 months.

RHHBY's P/E Growth Rating (100) in the null industry is in the same range as SNPHF (100). This means that RHHBY’s stock grew similarly to SNPHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHBYSNPHF
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
52%
Momentum
ODDS (%)
Bearish Trend 2 days ago
48%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
47%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
49%
Bullish Trend 2 days ago
38%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
27%
Advances
ODDS (%)
Bullish Trend 7 days ago
51%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
45%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
48%
Aroon
ODDS (%)
Bullish Trend 2 days ago
39%
Bullish Trend 2 days ago
16%
View a ticker or compare two or three
Interact to see
Advertisement
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QUAYX72.80N/A
N/A
AB Small Cap Growth Advisor
STOFX30.12N/A
N/A
Allspring Large Cap Growth C
ASGTX5.25N/A
N/A
Transamerica Small Cap Growth A
WOOOX16.57N/A
N/A
JPMorgan SMID Cap Equity R3
DFEOX45.46-0.37
-0.81%
DFA US Core Equity 1 I

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
-1.61%
RHHVF - RHHBY
65%
Loosely correlated
-1.58%
NVS - RHHBY
37%
Loosely correlated
-1.13%
JNJ - RHHBY
37%
Loosely correlated
-1.05%
RHHBF - RHHBY
32%
Poorly correlated
N/A
BMY - RHHBY
28%
Poorly correlated
-1.92%
More

SNPHF and

Correlation & Price change

A.I.dvisor tells us that SNPHF and RHHVF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHF and RHHVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHF
1D Price
Change %
SNPHF100%
N/A
RHHVF - SNPHF
7%
Poorly correlated
-1.58%
PTKFY - SNPHF
6%
Poorly correlated
N/A
PTKFF - SNPHF
2%
Poorly correlated
N/A
RHHBY - SNPHF
2%
Poorly correlated
-1.61%
SNPHY - SNPHF
1%
Poorly correlated
N/A
More